Tel:+86-21-51950625 51950635
Email us at
sales@koutingchina.com
Home
Company Profile
Products
KTY
Dapagliflozin impurities
API
Cyclobenzaprine impurities
Penciclovir Impurities
Clonazepam impurities
Tranexamic acid impurities
Duloxetine impurities
Thioctic Acid impurities
Levofloxacin impurities
Afatinib impurities
Edaravone impurities
Paliperidone impurities
Lurasidone impurities
Nifekalant impurities
Rebamipide impurities
Lesinurad impurities
Alogliptin impurities
Ibrutinib impurities
Zolpidem impurities
Lipoic acid impurities
Linezolid impurities
Sitafloxacin impurities
Salbutamol impurities
Rotigotine impurities
Sodium valproate impurities
Levetiracetam impurities
Sitagliptin impurities
Chlorzoxazone impurities
Gimeracil impurities
Rupatadine impurities
Azilsartan impurities
Tedizolid impurities
Parecoxib impurities
Palbociclib impurities
Group Buys
Custom Synthesis
News
Contact
Products
CAS No.
3,6-dichloropyrazine-2-carbonitrile
356783-16-9
(2-bromo-6-nitrobenzyloxy)(tert-butyl)dimethylsilane
1147531-02-9
3-bromo-4-dimethylamino-benzaldehyde
56479-63-1
1-broMo-2-Methyl-3,4-dinitrobenzene
290353-57-0
4-broMo-3-Methylbenzene-1,2-diaMine
952511-74-9
METHYL 2,4-DIBROMOBENZOATE
54335-33-0
1,3-DibroMo-2-(broMoMethyl)benzene
93701-32-7
2-aMino-6-broMo-3-fluorobenzoic acid
1153974-98-1
methyl 1-(4-bromophenyl)-3-oxocyclobutanecarboxylate
1364663-42-2
Methyl 4-(2-methoxy-2-oxoethyl)-3-nitrobenzoate
334952-07-7
N-ETHYL-N-(4-FLUOROPHENYL)AMINE
405-67-4
N,2-diMethylbenzaMide
2170-09-4
1-(2-Methoxy-6-(4-Methoxybenzyloxy)phenyl)ethanone
1234015-61-2
1-(2-hydroxyphenyl)-2-phenylethanone
2491-31-8
1-chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole
69352-04-1
251
252
253
254
255
256
257
258
259
260
Products are for research use only. Not for human use. We do not sell to patients.
Copyrigh ©2009,China Kouting Group Limited All Rights Reserved. Supported by
hxchem.net
products
Customer Service
Why Choose Us?
How to Order
How to Ship
How to Return
Frequently Asked Questions
Terms and Conditions
Email:
sales@koutingchina.com
Skype:
Notice